Inhibikase Grants Stock Options to Five New Employees
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) granted stock options to five newly hired non-executive employees covering a total of 685,718 shares under its 2026 Inducement Equity Plan. The …
Inhibikase Grants Stock Options to Five New Employees Read More